The University of Southern Mississippi

The Aquila Digital Community
Dissertations
Fall 10-11-2021

Human 5’-tailed Mirtrons are Processed by RNaseP
Mohammad Farid Zia

Follow this and additional works at: https://aquila.usm.edu/dissertations
Part of the Bioinformatics Commons, Cell Biology Commons, Computational Biology Commons,
Genetics Commons, Genomics Commons, Molecular Biology Commons, and the Molecular Genetics
Commons

Recommended Citation
Zia, Mohammad Farid, "Human 5’-tailed Mirtrons are Processed by RNaseP" (2021). Dissertations. 1962.
https://aquila.usm.edu/dissertations/1962

This Dissertation is brought to you for free and open access by The Aquila Digital Community. It has been accepted
for inclusion in Dissertations by an authorized administrator of The Aquila Digital Community. For more
information, please contact Joshua.Cromwell@usm.edu.

HUMAN 5’-TAILED MIRTRONS ARE PROCESSED BY RNASEP

by
M. Farid Zia

A Dissertation
Submitted to the Graduate School,
the College of Arts and Sciences
and the School of Biological, Environmental, and Earth Sciences
at The University of Southern Mississippi
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy

Approved by:
Dr. Alex S. Flynt, Committee Chair
Dr. Mohammed Elasri
Dr. YanLin Guo
Dr. Fengwei Bai
Dr. Hao XuName of Committee Member

December 2021

COPYRIGHT BY

M. Farid Zia

2021

Published by the Graduate School

2

ABSTRACT
microRNAs are pervasive small noncoding ~22 nt gene regulators that
collectively control the expressions by destabilizing mRNA or repressing translation.
Several thousand of miRNA genes have been reported in mammalians that mostly are
generated through canonical pathway while non-canonical miRNAs are not always
generated in the same pathways. Mirtrons are one of miRNA variations that bypass
Drosha cleavage step and instead are produced by splicing mechanism. There are 3
classes of mirtrons: conventional, 5’- and 3’-tailed. In tailed mirtrons, splicing defines
both pre-miRNA hairpin ends. Plenty of studies have been done on mirtrons but still 5’tailed mirtrons processing has remained unclear. Here, we studied the biogenesis of
human 5’-tailed mirtrons and the role of Ribonucleases in processing the tails. To address
this, we engineered miR-5010 tail on the 5p end and examined their biogenesis changes.
Our analysis on RNA sequencing revealed that in miR-5010, RNase P complex is
involved in processing the 5p tails by its endoribonuclease activity. We also
demonstrated that when Rpp30 (subunit of RNase P) is downregulated, the mirtrons
undergo “Arm Switching”. Besides, XRN family exoribonucleases seem to degrade the
5’-tailed mirtrons that have not been processed by the RNase P complex.
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CHAPTER I - INTRODUCTION
1.1 Non-Coding RNAs
Messenger RNAs (mRNAs) are the middlemen of information flow in cells being
intermediates between DNA and proteins. However, many RNA molecules are noncoding RNAs (ncRNA) functioning by regulating mRNAs (Delihas, 2015;
Diamantopoulos, Tsiakanikas, & Scorilas, 2018). As the name implies, ncRNAs are
RNAs that do not code for protein, splitting them from mRNA, their coding counterparts.
The first ncRNAs were identified in the late 1950s with the discovery of transfer RNAs
(tRNAs) and ribosomal RNAs (rRNAs), and since then other classes have surfaced
(Palazzo & Lee, 2015; P. Zhang, Wu, Chen, & Chen, 2019), such as microRNAs
(miRNAs), small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and others
(Mattick & Makunin, 2006; Shahrouki & Larsson, 2012). This ncRNA family is much
larger compared to coding RNAs. Alteration in the expression of ncRNAs, may
contribute to pathological phenotypes including cancers and diseases such as
Alzheimer’s, Autism, and heart diseases and this makes them a very broad and
significantly important area of study (Knoll, Lodish, & Sun, 2015; Wang, Han, Sun,
Chen, & Chen, 2019; L. Zhou et al., 2018). These findings suggest that ncRNAs are
associated with the complexity of prokaryote and higher eukaryotes involved in a
plethora of diverse functions (Geisler & Coller, 2013). Different ncRNAs have role in
different cellular processes where mostly are involved in translation and regulations. In
addition, they function in RNA splicing and DNA replication (Cheng et al., 2005;
Mattick & Makunin, 2006). ncRNAs are divided into two main categories according to
their transcript sizes: long non-coding RNAs (lncRNAs) which are longer than 200 nt and
1

small non-coding RNAs (sncRNAs) with a length typically lower than 100 nt. The small
ncRNAs are generated through a variety of pathways (Menezes, Balzeau, & Hagan,
2018; K. Miyoshi, T. Miyoshi, & H. Siomi, 2010; Okamura, Hagen, Duan, Tyler, & Lai,
2007; Ragusa et al., 2017).

1.2 MicroRNAs
miRNAs are small non-coding ~22 nucleotides RNAs which are mostly
transcribed by RNA polymerase II and processed into precursor miRNA (pre-miRNAs)
by folding into a stem- loop structure. The ubiquitous presence of different miRNAs
along with their target sites in many living organisms suggests an evolutionary ancient
origin and strong conservation (Ladewig, Okamura, Flynt, Westholm, & Lai, 2012;
Xiong, Schneider, Hulsey, Meyer, & Franchini, 2019). Thousands of miRNAs have been
discovered in plants, animals, fungi and viruses indicating an ancient origin of evolution.
Many families of miRNAs as well as their target sites are conserved among species
which demonstrates similar evolutionary pathways (Xiong et al., 2019). These small
RNAs bind to effector proteins, Argonautes (Ago), to form RNA-Induced Silencing
Complex (RISC) complexes. The miRNA guides the complex to the targets typically
found in the 3’ UTR of the mRNAs and form Watson-Crick base pairing (Ma et al., 2005;
O'Brien, Hayder, Zayed, & Peng, 2018; Parker, 2010; Parker, Roe, & Barford, 2005).
Then miRNAs trigger deadenylating and decapping of the target mRNA with
collaboration of Ago and several other proteins. Therefore, the poly(A) tail of the mRNA
and the 5’ cap cannot synergize which results in the translational inhibition of the
mRNAs (Okamura et al., 2007). A single microRNA can regulate the expression of
2

several mRNAs and a single mRNA may be regulated by more than one miRNA (Bartel,
2018; Flynt, Greimann, Chung, Lima, & Lai, 2010; Ragusa et al., 2017). miRNAs play
critical roles in cellular development and processes and as such they are linked to a
number of complex diseases from cancers to fertility and growth complications. For
example, miR-196a, miR-124a and miR-132 have been reported to be associated with
esophageal squamous cell carcinomas, neurodegenerative disease and Huntington’s
disease, respectively (Bloomston et al., 2007; C. Chen, Zhang, Zhang, Weakley, & Yao,
2011; Fendereski et al., 2017; Tam, de Borja, Tsao, & McPherson, 2014). Additionally,
miR- 34/449 are implicated with male and female infertility as well as growth retardation.
Therefore, it is inferred that miRNAs greatly influence the expression patterns of many
genes with different functionalities (Ardekani & Naeini, 2010; K. Miyoshi et al., 2010;
Xu et al., 2013).

1.2.1 miRNAs: A Historical Perspective
miRNAs were first noted in early 1990s when a 22 nucleotide RNA transcript of
the lin-4 gene in nematode Caenorhabditis elegans was discovered to be controlling
another gene’s expression, lin-14. Without coding for any protein, lin-4 was decreasing
the level of lin-14 expression. After that, Lee et al. discovered that there is a sequence on
lin-4 which is complementary to the 3’ Untranslated Region of the lin-14 mRNA. Then,
they postulated that an endogenous small RNA transcript is decreasing gene expressions
(R. C. Lee, Feinbaum, & Ambros, 1993). Therefore, lin-4 was named the first miRNA
capable of regulating the gene expression via partial base pair complementary with
mRNAs. However, this was dismissed due to lack of homologs in other organisms
3

concluding that probably this has been an isolated example in worms resulting in gene
knockdown. However, several years after that when the same mechanisms were detected
extensively distributed in eukaryotes, these small RNAs were categorized as a class of
regulatory molecules (Lau, Lim, Weinstein, & Bartel, 2001; R. C. Lee & Ambros, 2001;
Wightman, Ha, & Ruvkun, 1993). Another miRNA (21 nt) was then discovered in 2000
in C. elegans. This small RNA was named let-7 and since it is highly conserved across
species, impacted the study of this specific miRNA (Kaufman & Miska, 2010). Let-7 was
also detected in human and is associated in the late larval stages in adult transition
(Reinhart et al., 2000) (Pasquinelli et al., 2000). Since then, several other short RNAs
were discovered and interests in this field have soared paralleled with increasing number
of miRNAs annotations across all species.

1.3 tRNAs
Transport RNAs (tRNA) are another class of noncoding RNAs that are involved
in the translation of mRNA coding sequence into proteins. There are more than 500
tRNA genes in the human genome and they are initially transcribed by RNA Polymerase
III in the nucleus to produce pri-tRNAs that undergo maturation process before they form
“Cloverleaf” conformation. At this point, they bear 5p and 3p tails as “Leader” and
“Trailer” sequences, respectively (Woese, Olsen, Ibba, & Soll, 2000). To become mature,
tRNAs encounter processing events including 5p leader processing performed by RNase
P complex and 3p trailer trimming performed by RNase Z family. A non-templated
“CCA” motif is added to their 3’ end of the resulting pre-tRNA from previous step by
CCA-adding enzyme. The yielded end-matured tRNAs are detected by “Exportin-t” to be
4

exported to the cytoplasm. It is vital for cell to generate sufficient mature tRNAs to
support the protein synthesis efficiently especially in fast growing cells (Ohira & Suzuki,
2011, 2016).

1.4 Mechanisms of microRNA Biogenesis
The biogenesis of most miRNA starts with Drosha a ribonuclease III which has
endoribonucleolytic activity and participates in RNA maturation in the cell nucleus.
miRNAs biogenesis is initiated by the transcription of pri-miRNAs (Fortin, Nicholson, &
Nicholson, 2002; O'Brien et al., 2018). Drosha is in association with a protein called
DGCR8 which is essential for the activity of Drosha. A “UGU” motif sequence in ~60%
of hairpin loops guides DGCR8 to find hairpin loop. Then, Drosha recruits “UG” and
“CNNC” motifs sequences on 5’ and 3’ flanking regions to situate on the hairpin and cut
nearly one helical turn into the stem 16-18 nt upstream of “CNNC” motif. The released
pre-miRNA is 55-80 nt long and leaves a 2-nucleotide overhang at the 3’ end, which
makes it available for Exportin-5 (XPO5) identification (Denli, Tops, Plasterk, Ketting,
& Hannon, 2004; Han et al., 2006; X. Zhang & Zeng, 2010). XPO5 is thought to be the
major gate for transporting the pre-miRNAs to the cytoplasm. It has been reported that
many miRNAs can be processed without XPO5. However, miR-320 requires XPO1
instead of XPO5 (Westholm & Lai, 2011). After exported to the cytoplasm, pre-miRNA
is further cut by Dicer, another ribonuclease III in associated with a partner protein
TRBP. Both strands are cut close to the hairpin loop and a miRNA duplex is generated
which contains the guide strand paired to the passenger strand with ~2 nt 3’ overhang on
each end. Subsequently, the miRNA duplex is loaded into the AGO to form the core of
5

the RISC complex (R. Li, Jia, Zou, & Zhao, 2014; K. Miyoshi et al., 2010; Ragusa et al.,
2017). There are 8 members of the AGO family in humans. AGO1-4 have the ability to
load miRNAs but only AGO2 has endonuclease activity. It has indicated that mice with
catalytically inactive AGO2 die shortly after birth (K. Miyoshi et al., 2010). Compared to

Figure 1.1: Canonical miRNAs Biogenesis Pathway. Canonical miRNAs
are processed by Drosha and Dicer to produce miRNA:miRNA* duplex.

other Argonaute members, AGO2 is different in N-terminus and the PAZ-PIWI domain
linkage space (Meister et al., 2004). The process starts by loading small RNA from the
Dicer activity into the AGO2. Then the PAZ domain recognizes the 3’ end of miRNAs
(Tang, 2005). The 5’ phosphate of miRNA is placed between PIWI and the Mid domains
of the AGO protein. The enzymatic activity of the PIWI domain cuts the passenger
6

strand. Argonaute then takes the miRNA to the target mRNA and induces mRNA
degradation or translational repression usually by binding to the 3’ UTR region. The
miRNA strands are selected as passengers or guides depending on the thermodynamic
stability of each end of the duplex. The strand with more stability on its 5’ terminal
nucleotides is selected as the passenger strand and is degraded, while the other strand
becomes mature miRNA (Figure 1) (Hutvagner & Simard, 2008; Y. K. Kim, Kim, &
Kim, 2016).

1.5 Non-Coding miRNAs
In 2007, 14 short introns were identified as an alternative pathway for miRNA
biogenesis. Small RNA clusters that originated from the outer edges of 56-nt introns.
These sets of reads were very similar to the sets observed for the miRNA:miRNA*
duplex. The sets were complementary to each other and that their 5’ ends were more than
3’ ends. In addition, the majority of the sets contained 2-nt 3’ overhangs which mimicked
them as Drosha products. Moreover, the predicted structure and the sequence were
conserved in a pattern similar to that of pre-miRNAs. Despite the similarities with
canonical miRNAs, pairing was stopped at the hairpin base and did not go over
miRNA:miRNA* duplex which is necessary for Drosha to cleave the pri-miRNA. In the
site that the pairing was extended, the reads showed conserved splice sites. This led them
to the idea that these miRNAs did not originate from the canonical miRNA biogenesis
pathway. Instead, an alternative pathway in which splicing defines pre-miRNA
processing rather than Drosha cleavage is in place (Figure 2.1). As in the structure
predictions, the terminal nucleotides characterize the first or last nucleotides of intronic
7

regions. They named their introns “Mirtron”s (Okamura et al., 2007; Ruby, Jan, & Bartel,
2007; Sibley et al., 2012). Moreover, tRNAs, rRNAs and some snoRNAs provide another
sources of non-canonical pre-miRNAs that are independent of microprocessor-mediated
processing. The initial excised structure when spliced forms a “Lariat” which is
linearized by Ldbr (Lariat Debranching) enzyme (Han et al., 2004; K. Miyoshi et al.,
2010; Seow, Sibley, & Wood, 2012; Zia & Flynt, 2018). Subsequently, the Ldbr
ribonucleolytic activity processes the 3’-lariat tail, linearizes the intron and forms premiRNA hairpins that are suitable targets for Dicer cleavage. The spliceosome is then
disassembled and recycled (Arenas & Abelson, 1997). Mirtrons then enter the canonical
miRNA biogenesis pathway and then are exported to the cytoplasm by XPO-5. However,
some studies have shown that mirtrons are not XPO-5 dependent and they utilizing other
mechanisms for exporting to cytoplasm besides XPO-5 (Seow et al., 2012). Three types
of mirtrons are conventional, 5’-tailed and 3’-tailed and splicing defines both ends of the
hairpins in the conventional mirtrons and both 5’ and 3’ tailed hairpins undergo
debranching by Ldbr and the 3’-tailed mirtrons are trimmed by the RNA exosome
(Figure 2.1) (Ladewig et al., 2012; Rorbach, Unold, & Konopka, 2018; Westholm & Lai,
2011). The importance of the splice sites is well-studied in a research group that
demonstrated artificial mirtrons have much higher knockdown efficiency than shRNAs in
targeting Myotonic Dystrophy Protein Kinase (DMPK). Additionally, they illustrated that
their knockdown efficiency is strongly related to their splice sites precision while Drosha
dependent miRNAs are less efficient in knocking down their targets because Drosha and
Dicer show fewer accuracy compared to spliceosome activity. This brings an advantage
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for mirtrons by having less off-targets (Seow et al., 2012; J. O. Westholm, E. Ladewig,
K. Okamura, N. Robine, & E. C. Lai, 2012).
Recently, 478 human loci have been identified as diced small RNA duplexes
derived from splicing which 242 of them are novel. Interestingly, most of the annotated
introns (86% of the whole mirtrons population) are 5’-tailed and 3’-tailed mirtrons only
have 3.6% of the totals. This represents the 5’-tailed mirtrons as, by far, the dominant
class of mirtrons in humans (J. Wen, E. Ladewig, S. Shenker, J. Mohammed, & E. C. Lai,
2015). Comparing expression of human canonical miRNAs (deep conserved or newly
evolved) to mirtrons inferred from small RNA sequencing data meta-analysis reveals that
mirtrons have on average several fold lower abundance (Griffiths-Jones, Grocock, van
Dongen, Bateman, & Enright, 2006). Furthermore, the distribution of mirtrons is
bimodal, showing that many species accumulate at the lowest levels of expression
observed for miRNAs (Figure 2.2). The type of mirtron in the lowest abundance
population are tailed varieties, consistent with the requirement for additional processing
during tail removal.

1.6 Regulation of Mirtrons Function by Uridylation
Several terminal modifications have been identified in pre- and mature miRNAs.
There are many reports about the effects of nucleotide addition on miRNA biogenesis,
functionality and stability (J. O. Westholm et al., 2012). Untemplated addition of adenine
and uridine is the most common modification in miRNAs at their 3’ end especially in
miRNAs which end in “guanine”. 5’-tailed and 3p-arms of conventional mirtrons
demonstrate more accumulations of this untemplated addition (J. Wen et al., 2015; J. O.
9

Westholm et al., 2012) and this addition is performed by a class of noncanonical Poly (A)
Polymerases (PAP) which later was discovered to be a Terminal Uridyltransferase
(Tailor) (Figure 1.2). Mirtrons demonstrate a bios over uridines and adenines additions to
the 3’-end. However, other nucleotides may be added but in a very lower rate (J. O.
Westholm et al., 2012). According to the organism and the examined miRNA, 3’
untemplated nucleotide addition shows various impacts on biogenesis and functionality
of mirtrons and miRNAs (Bortolamiol-Becet et al., 2015; Gutierrez-Vazquez et al.,
2017).

Figure 1.2: TUTase. Mirtrons are uridylated due to their 3’ terminal Guanyl
which makes them good substrates for Tailor.
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Uridylation mostly inhibits the biogenesis of mirtrons Altogether, 3’ nucleotide
addition has vital regulatory role in gene expression (Yashiro & Tomita, 2018). But if this
pathway suppresses their biogenesis, what is its utility? The answer could be found by
considering evolutionary context. Tailor prefers splicing derived miRNAs, and this
makes mirtrons more accessible for uridylation than canonical miRNAs particularly since
the 3’ terminal “AG” which is mirtron’s 3’ splice site nucleotides is Tailor sequence
preference as well. This preference is regardless of being lower or higher expressed, well
conserved or newly evolved. Therefore, it is possible that the mirtrons uridylation
suppresses their biogenesis to make them less predisposed to deletions or mutations
excluding them from the evolution. This can make extra evolutionary obstacles for
mirtrons incorporation into conserved networks (Bortolamiol-Becet et al., 2015;
Mohammed, Flynt, Siepel, & Lai, 2013; J. O. Westholm et al., 2012).

1.7 Hypothesis
In previous studies, it was inferred that tail processing of mir-1017, which is a 3’tailed mirtron, occurs through exonuclease activity. Although we don’t overlook the
probable role of exoribonucleases in this process, we wanted to determine if any other
mechanisms such as endoribonuclease activities are involved in 5’-tailed mirtrons
biogenesis. Since it has been reported that exoribonucleases and specifically exosome is
trimming the 3’- tailed mirtrons (3’ to 5’ processing), it is inferred that there might be an
endoribonuclease activity involved in the process from 5’ to 3’ (Flynt et al., 2010;
Westholm & Lai, 2011). Furthermore, in several studies, it has been demonstrated that
11

endoribonucleases play key roles in biogenesis or repair systems in tRNA processing on
their 5’ end and it appears that RNase P is the most important contributor in maturation of
tRNAs by its endonuclease activity (Cho et al., 2019; Dutta, Malhotra, & Deutscher,
2012; Spath, Canino, & Marchfelder, 2007; Takaku, Minagawa, Takagi, & Nashimoto,
2003; Willkomm & Hartmann, 2007; Yip, Savickas, Gygi, & Shao, 2020). Among
several well-known endoribonucleases, RNase P has been one of the most well-studied
complexes and its contribution in 5’ to 3’ RNA processing at the junction between the 5’
end of double-stranded and single- stranded region of RNA is proved frequently in
different studies (Altman, 2011; N. Jarrous, 2002; Willkomm & Hartmann, 2007).
Consequently, all these led us to hypothesize that an endoribonuclease is in charge of 5’tailed mirtrons processing and it appears reasonable to focus the efforts on RNase P.

1.8 Significance
There are a few obscurities in the 5’-tailed mirtron processing mechanism that
requires illumination. One of the most important questions that we are trying to answer in
this study is to understand the mechanism by which 5’-tailed mirtrons are processed.
Specifically, it is important to identify the enzymes that are involved in their maturation.
Since mirtrons bypass Drosha cleavage, clarifying whether 5’-tailed mirtrons undergo
individual events and enzymatic reactions to process their tails appears to be an important
step towards unravelling details about their biogenesis. This unsolved issue demonstrates
the significance of the study specifically because there are no published studies reporting
the responsible factor(s) involved in 5’-tailed mirtrons maturation. This is while these
mirtrons are the most abundant mirtrons. Moreover, knocking down or replacement of the
12

pathogenic alleles by RNAi are attracting more attentions in therapeutic interventions
recently. Mirtrons are reported to be promising as alternatives to siRNAs, shRNAs and
artificial miRNAs in this field. Therefore, exploitation and development of their unique
properties will advantage future studies and therapeutic applications (Seow et al., 2012).

1.9 Objective
Mirtron 5010 comes from introns of Vacuolar -ATPase (V-ATPase) domains
which are multi-subunit enzymes that mediate acidification in eukaryotes for zymogen
activation, protein sorting and other intracellular processes (Gorelick, Shugrue,
Kolodecik, & Thrower, 2006; Holliday, 2017). mir-5010 located on chromosome 17 is
annotated on the basis of ~ 2200 small RNA reads present in miRbase.org database. miR5010 regulates many genes that have key roles in cell cycles (Flynt et al., 2010). Also,
miR-668 a 3’-tailed mirtron located on chromosome 12 of mouse genome was selected as
a control.
To perform the experiments to achieve our goal, we designed changes in the tail
regions of the two mirtrons (one 5’- and one 3’-tailed) and then transfected the HEK cells
with the constructs. Repetitive G-rich sequences are most-likely forming “G quartets”
which cause the concluded hairpins become more stable than other structures without
poly G tract (Lerner & Sale, 2019). Therefore, our first objective would be uncovering
the mechanism (endoribonuclease or exoribonuclease) involved in processing the 5’tailed mirtrons. Afterwards, determining which exact ribonuclease(s) is(are) processing
the 5’ tails in mirtrons will be our next objective. For this purpose, we will knockdown
selected ribonucleases that have this potential using sequencing. The last step will be
13

confirming our hypothesis through RNA sequencing data analysis along with enzyme
assay and Immunoprecipitation on determined ribonuclease.
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CHAPTER II – DETECTION OF TAILED MIRTRONS BY NORTHERN BLOTTING
2.1 Abstract
microRNAs (miRNAs) have vital roles in regulating gene expression–
contributing to major diseases like cancer and heart disease. Over the last decade
thousands of miRNAs have been discovered through high throughput sequencing-based
annotation. Different classes have been described, as well as a great dynamic range of
expression levels. While sequencing approaches provide insight into biogenesis and
allow confident identification, there is a need for additional methods for validation and
characterization. Northern blotting was one of the first techniques used for studying
miRNAs and remains one of the most valuable as it avoids enzymatic manipulation of
miRNA transcripts. Blotting can also provide insight into biogenesis by revealing RNA
processing intermediates. Compared to sequencing, however, northern blotting is a
relatively insensitive technology. This creates a challenge for detecting low expressed
miRNAs, particularly those produced by inefficient, non-canonical pathways. In this
chapter, we describe a strategy to study such miRNAs by northern blotting that involves
ectopic expression of both miRNAs and miRNA-binding Ago proteins. Through use of
epitope tags, this strategy also provides a convenient method for verification of small
RNA competency to be loaded into regulatory complexes.
Keywords
miRNA; mirtron; tailed-mirtron; low-abundance detection; RNAimmunoprecipitation; northern blot
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2.2 Introduction
Small non-coding RNAs are common features of eukaryotic transcriptomes that
require specialized detection methods due to their small size. Moreover, many species are
present in low abundance, which further complicates detection (Q. Huang, Mao, Li, Hu,
& Zhu, 2014). microRNAs are an ~23 nucleotide (nt) class of small RNAs that have vital
roles in gene regulation and their dysregulation is associated with numerous diseases
(Fendereski et al., 2017; Westholm & Lai, 2011). Animal microRNAs are a highly
diverse class of genes. Some miRNAs are ancient, predating the birth of metazoans,
while other are newly evolved and species specific (Meunier et al., 2013). Accordingly,
microRNAs are a highly diversified class of transcript. High throughput sequencing has
been instrumental in small RNA discovery. Indeed, thousands of miRNAs have been
discovered and deposited into databases (Berezikov, 2011; Witten, Tibshirani, Gu, Fire,
& Lui, 2010; J. Zhou et al., 2015). Yet, compared to the number of miRNAs annotated,
there have been very few functional studies, suggesting there is a need for additional
strategies for detection.
miRNA biogenesis typically involves cleavage from hairpin RNAs precursors
(premiRNAs). For most miRNAs the Drosha/DGCR8-containing microprocessor
complex excises pre- miRNA from primary transcripts. Final processing is then carriedout by Dicer, yielding miRNA/miRNA* duplexes (Ketting et al., 2001; Y. Lee et al.,
2003). One strand then is loaded into Argonuate (Ago) proteins where it participates in
targeting and repression of transcripts (J. E. Babiarz, Ruby, Wang, Bartel, & Blelloch,
2008; Song, Smith, Hannon, & Joshua-Tor, 2004). Beyond this canonical pathway, there
are many atypical pathways. Multiple varieties of miRNAs have been found to bypass
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Drosha/Dgcr8 processing like mirtrons, shRNAs, snoRNA-derived miRNAs, tRNAderived miRNAs, and rRNA-derived miRNAs (Figure 2.1) (J. E. Babiarz et al., 2008;
Ender et al., 2008; Maute et al., 2013; Ruby et al., 2007; Yoshikawa & Fujii, 2016)
In this article, we will focus on the detection of mirtrons. They are derived from
small introns that after splicing and debranching can fold into small hairpins (Curtis,
Sibley, & Wood, 2012; Macfarlane & Murphy, 2010; Westholm & Lai, 2011). Hundreds
of mirtrons have been discovered in the human genome through inspecting hairpins
coincident with splice sites from which small RNA sequencing reads are derived
(Ladewig et al., 2012). Mirtrons are classified in three categories: conventional, 3’-tailed,
and 5’-tailed. In conventional, both hairpin ends correspond to splice sites and after
splicing can become dicer substrates. In “tailed” varieties only one side of the hairpin is

Figure 2.1: Classes of miRNA defined by biosynthesis pathway. rRNAs, tRNAs and
snoRNAs can be sources of miRNAs as non-canonical pathways.
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at a splice site, while the other side has a stretch of nt’s, or tail, between the hairpin base
and splice site (J. Wen et al., 2015; Westholm & Lai, 2011). Studies in Drosophila have
also found that mirtrons are commonly modified by Tailor, a TUTase (terminal
Uridyltransferase), which uridylates hairpins to inhibit their biogenesis by abrogating
Dicer processing (Norbury, 2013). Thus, mirtrons more so than other types of miRNAs
are less robustly expressed than canonical miRNAs.
Comparing expression of human canonical miRNAs (deep conserved or newly

Figure 2.2: RDI Plot.
Showing the distribution of normalized (Reads per million) miRNA expression
separated by class. Values were taken were taken from miRbase.

evolved) to mirtrons inferred from small RNA sequencing data meta-analysis reveals that
mirtrons have on average several fold lower abundance (Figure 2.2) (Griffiths-Jones et
al., 2006). Furthermore, the distribution of mirtrons is bimodal, showing that many
species accumulate at the lowest levels of expression observed for miRNAs (Figure 2.2).
The type of mirtron in the lowest abundance population are tailed varieties, consistent
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with the requirement for additional processing during tail removal. Therefore, detection
strategies capable of detecting tailed-mirtrons via northern blotting will be applicable for
studying all types of low abundance miRNAs. Northern blotting was the first technique
used to detect a miRNA transcript (R. C. Lee et al., 1993). Many techniques have been
developed in the interim which frequently rely on reverse transcription and PCR, which
can introduce bias, artifacts, and mostly can’t distinguish between biogenesis
intermediates (Sharbati-Tehrani, Kutz-Lohroff, Bergbauer, Scholven, & Einspanier,
2008; Varkonyi-Gasic, Wu, Wood, Walton, & Hellens, 2007). The challenge in using
northern blotting is relatively low sensitivity, making detection of tailed-mirtrons
problematic. Despite this difficulty, it is possible to detect tailed-mirtrons using ectopic
expression of the miRNA and Ago proteins (Ladewig et al., 2012). In this chapter, we
describe a protocol for applying this technique to study mammalian tailed-mirtrons. This
process involves transfection of two constructs, one to express the mirtron and the other
to express a myc-tagged human Ago2 (Figure 2.3 a). In this system, the mirtron is cloned
into the open-reading frame of GFP, producing a fluorescent reporter for verification that
splicing has occurred efficiently. This strategy also takes advantage of a cell culture
phenomena where increased rates of miRNA biogenesis are observed in cells grown to
high confluency (Hwang, Wentzel, & Mendell, 2009). Thus, it is critical to use a cell line
that does not exhibit contact- inhibition. The protocol described here uses Hela cells.
Following transfection RNAs can either be bulk isolated by a routine RNA purification
method like TriZol extraction or through immunoprecipitation targeting the myc epitope
fused to Ago2. Northern blotting, as previously described, involving urea-PAGE
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separation and transfer to nylon membranes can then be used to visualize RNAs in

Figure 2.3: System for detecting and verifying mammalian mirtrons.
a) Constructs for co-transfection. Top vector configured to couple mirtron splicing to GFP
expression, by interrupting the GFP ORF with the mirtron-containing intron. Bottom vector
for ectopic expression of Ago2-myc b) Northern Blotting reveals expression of miR-5010, a
5’-tailed mirtron, using the vectors in (a) in conjunction with an immunoprecipitation
procedure.

conjunction with oligonucleotide probes (Figure 2.3b) (Rio, 2014).

2.3 Protocol
2.3.1 Plasmid Constructs
Mirtrons are amplified and inserted into expression vectors within opening
reading frame of GFP [29]. The protocol also utilizes a myc-tagged hAgo2 (Addgene:
Plasmid #19872). Plasmid DNAs are isolated via commonly-used commercial
purification kits like the Qiagen®Endo-free Maxi Prep Kit.
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2.3.2 RNA Immunoprecipitation
Phosphate buffered Saline, lysis buffer (5% Glycerol, 150mM sodium chloride,
2mM Magnesium Acetate, 20mM, Tris 7.5 pH, 0.5% NP-40, 2mM DTT, 40 units/mL
RNase Out ® Invitrogen, and Complete mini Protease Inhibitor Cocktail ® Roche). Lysis
buffer should be used within several days of mixing and kept at 4°C.
Protein G Dynabeads ® Invitrogen, magnetic stand, and tween-20.
Anti-myc (clone 9E10, Thermofisher) and a control IgG (Jackson
Immunoresearch) antibodies.
Bead preparation and RNA isolation: TRIzol ® Invitrogen, or 400 mM sodium
chloride, acid phenol chloroform (Ambion), glycogen co-precipitant, isopropanol, 70%
ethanol, and sodium acetate pH 5.3.
Hela cells are maintained in DMEM (Dulbecco’s Modified Eagle’s Medium)
supplemented with 10% FBS and 1% penicillin/Streptomycin using standard cell culture
methodology. Hela cells are efficiently transfected with Lipofectamine 3000 (Invitrogen)
to deliver mirtron and myc-Ago2 encoding plasmids, as described above. Transfection
and splicing efficiency is determined by visualizing GFP fluorescence.
a. Grow cells to 100% confluency, and change media 3 hours before transfection
with antibiotics free media.
b. Warm OptiMEM to room temperature. Make a mixture of OptiMEM, Plasmids,
and Lipofectamine 3000 based on the scale of transfection in accordance with
manufacturer recommendations. For this protocol six well plates are typically
used.
c. Incubate the mixture at room temperature for 20–25 minutes.
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d. Add the transfection mixture to the cells dropwise, without touching the plate
wall. 3.1.5) Swirl the dish gently and incubate for 2 days (37°C, 5% CO2).
e. Check transfection efficiency two days after transfection.

2.3.3 RNA Isolation
Following the two-day incubation RNA is harvested. This could be done using the
TRIzol method, following manufacturer protocols, or immunoprecipitation to isolate
Ago-miRNA complexes.
a) TRIzol extraction (optional)
b) Add TRIzol directly to tissue culture plates. Cells should immediately become
opaque, and easily dislodged by micropipetting. Remove cells and place in
microcentrifuge tube.
c) Incubate TRIzol and cells for 10 mins at room temperature.
d) Add 200 μl of chloroform to every 1 mL of TRIzol and incubate at room
temperature for 5 mins.
e) Separate phases at 4°C for 15 mins by spinning at 13,000 rpm.
f) Transfer the clear aqueous phase to an equal volume of isopropanol and
incubate overnight at −20°C.
g) Spin precipitations at 4°C for 30 mins, resuspend pellets in RNase free water,
and measure concentration via spectrophotometry.
h) Immunoprecipitation of miRNA-Ago Complexes (optional).
i) Wash transfected cells with ice-cold PBS twice while in culture dish. Add
lysis buffer to cells and incubate 20 mins on ice. Cell layer should begin to
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detach from the bottom of the dish with gentle micro pipetting. Transfer to
microcentrifuge tube, mix well with pipette to eliminate clumps, and spin
down at 13000 rpm for 20 minutes at 4°C to clarify lysate. Transfer
supernatant to new tube.
j) Prepare beads for incubation with lysate. Add protein G magnetic beads to
tubes (two tubes for each sample). Place the tubes on a magnetic stand and
remove the supernatant. Wash tubes twice with PBS containing 0.02% tween20. In PBS-tween add Anti-myc or control IgG antibodies.
k) Remove PBS tween from beads and add cell lysate from step 3.2.1.1. Reserve
10% of the volume to be used as input control. Place on rocker for 2 h, 4°C.
l) Wash beads with lysis buffer five times using magnetic stand to remove beads
from solution.
m) Add equal volumes of 400mM NaCl and acid phenol chloroform to beads.
Aggressively vortex. This procedure should also be performed on the reserved
10% volume of lysate set aside for input control.
n) Separate phases at 4°C for 15 mins by spinning at 13,000 rpm.
o) Add clear aqueous phase to an equal volume of isopropanol and incubate
overnight at −20°C.
p) The following day spin precipitations at 4°C for 30 mins, resuspend pellets in
RNA II loading buffer.
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2.3.4 Northern Blotting
a) Sample Preparation. If immunoprecipitation was performed samples are ready to
load on the gel. If TRIzol extraction was used, 20μg of RNA should be loaded in
each lane.
b) Reprecipitate 20μg of RNAs by adding the appropriate volume of RNA to 100%
ethanol containing 300 mM sodium acetate.
c) Incubate the RNA at −20°C for at least one hour.
d) Spin precipitations at 4°C for 30 mins, resuspend pellets in RNA II loading
buffer.
e) RNAs dissolved in RNA II loading buffer are denatured by incubating at 94°C for
3 minutes and then immediately placed on ice.
f) Prepare and Run Gel using a vertical gel rig and the UreaGel system. 3.3.2.1) Mix
UreaGel diluent, buffer, and concentrate, then add APS and TEMED.
g) Quickly, using a large volume pipette pour gel mixture between glass plates,
insert comb, and lay horizontally until gel is set.
h) Place gel on apparatus and fill buffer tanks with TBE. Pre-run the gel at 250 V for
30 minutes.
i) Using long gel loading tips transfer RNA dissolved in RNA II loading buffer to
the wells of the gel. Prior to loading samples, wells should be washed out to
remove urea that has diffused into the space. Radio-labeled decade marker should
also be loaded on the gel.
j) Run the gel at 250–350 V until the fastest moving, bromophenol blue dye band
has migrated approximately eight inches.
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k) Blotting of RNAs onto nylon membranes.
l) Soak filter paper in 0.5X TBE buffer and place onto wet-dry transfer rig.
m) Crack the gel using a separator wedge, and cut the region of the gel to be blotted.
The lower dye band corresponds to ~10 nt RNAs. The gel should be cut
approximately one inch below the lower band in order to capture all the RNA
molecules.
n) Place the gel onto the 0.5X TBE soaked filter paper.
o) Prepare the membrane by quickly rinsing in water, followed by briefly soaking in
0.5 X TBE. Once the membrane sinks in the buffer it is ready to be placed on top
of the gel.
p) Place another presoaked piece of filter paper on top of the membrane.
q) Place the lid on the rig. The filter paper/gel/membrane should be sandwiched
tightly between the electrodes.
r) Transfer the RNAs to the membrane for 30 mins at 10V at 4°C.
s) Remove membrane from transfer apparatus, and air dry briefly on a paper towel.
t) Crosslink the RNAs to the membrane with UV exposure.
u) Bake the blot at 80°C for 30 mins 3.3.4) Probing and visualizing membranes.
v) Blots are place into cylindrical hybridization tubes along with enough
hybridization buffer to keep the blot wet.
w) Prehybridize blots for >1 hour at 40–45°C, in a rotating hybridization oven.
x) Prepare radio-labeled probes by mixing water, complementary DNA oligo, 10X
PNK buffer, PNK, and gamma-P32ATP 6000uCi/mL.
y) Incubate the labeling reaction at 37°C for > 1hour.
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z) Stop the reaction by adding EDTA.
aa) Remove unincorporated radionucleotides using G-25 sephadex columns. Remove
buffer from column by spinning at 2000rpm for 4 min. Transfer the probelabeling reaction to the column and spin again for 2000rpm, 4 min. The probe is
in the column flowthrough.
bb) Add the radiolabeled probe to the hybridization solution. Avoid touching the
membrane with concentrated probe.
cc) Incubate the membrane overnight at 40–45°C in a rotating hybridization oven.
dd) Wash and expose the blot.
ee) Wash the membrane twice with high stringency wash buffer at the hybridization
temperature for one hour.
ff) Wash the membrane twice with low stringency wash buffer at the hybridization
temperature for one hour.
gg) Remove membranes from tubes, and dab on filter paper. Do not over-dry the
membrane. The objective is to remove excess liquid.
hh) Wrap the membrane with cling wrap and expose to X-ray film or to
phosphorimager screens.
ii) Develop films or scan screens after one day.

2.3.5 Reprobing Membrane
a) Signal can be stripped from blots by boiling membranes in 0.1% SDS. Blots
should be placed in boiling solution and left to cool for three hours. This
should be repeated once.
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b) Following the stripping procedure, blots are placed into hybridization buffer
and the procedure repeated starting at step w.
c) Blots can be subject to multiple reprobings before the integrity of the
immobilized RNA is compromised.

2.4 Notes
A) The protocol described here relies on a radiolabel to visualize the interaction
of probes with RNAs immobilized on blots. There are alternatives to this type of
detection, which are untried with mirtrons [30]. These procedures involve an epitope
labeled probe such as biotin followed by antibody detection leading to visualization
through chemiluminescence. For labs that want to avoid isotope this could be a viable
alternative.
B) This protocol calls for DNA oligonucleotide probes, but is also appropriate for
use with LNA-based probes. These molecules offer greater specificity compare to DNA
probes. To use this alternative chemistry the hybridization buffer should be substituted
with a formulation containing formamide.
C) LNA hybridization buffer: 50% Formamide, 5X SSPE, 5x Denhardt’s, 0.5%
SDS, 20ug/ml ssDNA.
D) Avoid touch nylon membranes with gloves, and then only on the edges. This
will avoid the appearance of blotting artifacts that might obscure signal.
E) Care should be taken to load the optimal amount of RNA ladder. The Decade
Marker protocol calls for a single μl of gamma-P32ATP 6000uCi/ml, but this could lead
to innapropriatly intense bands that obscure signal if not properly diluted. When fresh
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ATP is used, the marker should be serially diluted in RNA II loading buffer. 1 μl of
reaction should be diluted in 30 μl followed by a second dilution in of 1 μl in 30 μl. One
μl of the final dilution should be loaded on the gel.
F) Following the final wash step it is typical to observe very little signal
emanating from the blot via Geiger counter. However, when signals are very weak longer
exposure times may be required. Experimenters could extend exposure times to a week
for the lowest signals.
G) When removing combs from UreaGels the wells should be washed
aggressively with water to prevent residual acrylamide from polymerizing and causing
unevenness in the bottom of the well which will result in RNA migration artifacts.
H) Moderation of voltage used during PAGE separation of RNAs is
recommended. This prevents bending of bands.
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CHAPTER III – HUMAN 5’-TAILED MIRTRONS ARE OROCESSED BY RNaseP
3.1 Abstract
Approximately a thousand microRNAs (miRNAs) are documented from human
cells. A third appear to transit non-canonical pathways that typically bypass processing
by Drosha, the dedicated nuclear miRNA producing enzyme. The largest class of noncanonical miRNAs are mirtrons which eschew Drosha to mature through spliceosome
activity. While mirtrons are found in several configurations, the vast majority of human
mirtron species are 5’-tailed. For these mirtrons, a 3’ splice site defines the 3’ end of their
hairpin precursor while a “tail” of variable length separates the 5’ base of the hairpin
from the nearest splice site. How this tail is removed is not understood. Here we examine
sequence motifs in 5’-tailed mirtrons and interactions with RNA turnover processes to
characterize biogenesis processes. Through studying the high confidence 5’-tailed
mirtron, hsa-miR-5010, we identify RNaseP as necessary and sufficient for “severing”
the 5’ tail of this mirtron. Further, depletion of RNaseP activity globally decreased 5’tailed mirtron expression implicating this endoribonuclease in biogenesis of the entire
class. Moreover, as 5’-tailed mirtron biogenesis appears to be connected to tRNA
processing we found a strong correlation between accumulation of tRNA fragments
(tRFs) and 5’-tailed mirtron abundance. This suggests that dysregulation of tRNA
processing seem in cancers also impact expression of the ~400 5’-tailed mirtrons encoded
in the human genome.
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3.2 Introduction
microRNAs (miRNAs) are small non-coding ~22 nucleotide (nt) RNAs processed
from stem-loop structures (Bartel, 2018). Biogenesis is initiated by the microprocessor
which contains Drosha, an RNase III enzyme, that crops ~70 nt precursor hairpin from
primary transcripts and leaves 2-nucleotide 3’ overhang. The overhangs are recognized
by Exportin-5 (XPO5), which carries pre-miRNAs to the cytoplasm for final processing
by Dicer, another RNase III, after which they are loaded into effector Argonaute (Ago)
proteins. Once recruited by Ago, miRNAs typically base pair with mRNAs via their 5’
nucleotides between position 2-9, inducing degradation or translational
repression(Grimson et al., 2007).
While most miRNAs mature through the standard Drosha-Dicer-Ago pathway,
numerous additional routes have been identified that take advantage of alternate RNA
processing enzymes (Keita Miyoshi, Tomohiro Miyoshi, & Haruhiko Siomi, 2010).
Indeed, miRNAs have been found to reside in most major non-coding RNA (ncRNA)
varieties such as tRNAs, rRNAs, and snoRNAs. Each of these ncRNAs are cut from
longer transcripts, cuts which are repurposed for creation of non-canonical miRNAs.
Among these the most prevalent variety is tRFs, which are found in numerous cell types
as a sign of stress and are diagnostic of an oncogenic phenotype (Guzzi & Bellodi, 2020;
Y. Zhang, Qian, He, & Gao, 2020). This makes many tRNAs dual functional molecules
with both tRNA and miRNA capabilities such as tRNA-Ile which can form a 110 bp
hairpin encoding hsa-miR-1983 which is also a mature tRNA molecule (Hasler et al.,
2016).
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Unsurprisingly, the most prevalent RNA processing event in eukaryotes, splicing,
also generates miRNAs outside the canonical pathway (Okamura et al., 2007; Ruby et al.,
2007; Sibley et al., 2012). miRNAs where the hairpin base is defined by splicesomemediated cuts are called mirtrons and were the first recognized class of non-canonical
miRNA. The initial set of mirtrons were minute introns where the precursor fold
comprised the length of the entire intron. After splicing, lariat intermediates are linearized
by Lariat Debranchase (Ldbr) permitting folding into structures that are suitable for
export, Dicer cleavage, and Ago loading. After this discovery, investigation of
microprocessor deficient ES cells showed additional types of mirtrons existed where only
one side of the hairpin corresponded to a splice site (Joshua E. Babiarz et al., 2011). On
the hairpin terminus that was not a splice site a “tail” of nucleotides extended to the
scissile base of a distant splice site. Studies in Drosophila revealed that removal of a 3’
tail is carried out by the 5’-3’ RNA exosome, which was previously found to be
confounded by terminal hairpins on substrates (Flynt et al., 2010). Critically, this
established a paradigm that generic turnover enzymes can participate in productive
miRNA biogenesis.
In addition to the alternate method of biogenesis, mirtrons also show a different
conservation profile relative to miRNAs. Approximately 80 animal miRNAs are
conserved in all metazoans while mirtrons, as well as other non-canonical miRNAs, are
rarely found shared at the order taxonomic level (Ladewig et al., 2012; Jiayu Wen, Erik
Ladewig, Sol Shenker, Jaaved Mohammed, & Eric C. Lai, 2015). Moreover, mirtron
biogenesis modes are not consistently represented. Three types of mirtrons are observed:
the original strict mirtrons where splicing generates both ends of the hairpins, 3’-tailed
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mirtrons where a 5’ splice site coincides with the hairpin base and a tail of nucleotides
extends to a distal 3’ splice site, and the 5’-tailed mirtrons where the hairpin base is a 3’
splice site with a tail between the hairpin and a 5’ splice site. Strict mirtrons are found
throughout animal genomes with only a handful of examples. Likewise, 3’-tailed
mirtrons are rare genomic features, which nevertheless are found in invertebrate and
vertebrates at approximately the same rate. Unlike the other mirtron configurations, 5’tailed mirtrons are extremely abundant in mammalian genomes, while essentially absent
or present at the same rate as 3’-tailed mirtrons in lower organisms. Approximately 450
human loci have been identified as sources of diced small RNA duplexes derived from
splicing, remarkably 86% are 5’-tailed mirtrons (Ladewig et al., 2012; Jiayu Wen et al.,
2015).
Other features further separate mirtrons from standard miRNAs. Comparing
expression of human canonical miRNAs to mirtrons shows mirtrons have on average
several fold lower abundances (Ladewig et al., 2012; Jiayu Wen et al., 2015; Zia & Flynt,
2018). This is potentially linked to a higher rate of terminal modifications identified on
pre- and mature miRNAs that occur on mirtrons (De Almeida, Scheer, Zuber, &
Gagliardi, 2018; Le Pen et al., 2018; J. O. Westholm et al., 2012). Mirtrons are highly
modified by untemplated addition of adenine and uridine carried out by noncanonical
Poly (A) Polymerases (PAP) or Terminal Uridyltransferase (TUTases) (BortolamiolBecet et al., 2015; Jakub O. Westholm, Erik Ladewig, Katsutomo Okamura, Nicolas
Robine, & Eric C. Lai, 2012). Nucleotide addition seems to lead to variety of impacts on
miRNA biogenesis and functionality; however, effects mostly appear to be inhibitory
(Bortolamiol-Becet et al., 2015; Gutierrez-Vazquez et al., 2017; Heo et al., 2008).
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Modification can make hairpins poor substrates for Dicer or shift the Dicer cleavage site
on the pre-miRNA by altering thermodynamic features and thereby modulating strand
selection by Ago (B. Kim et al., 2015; H. Kim et al., 2020; Yang et al., 2019). Strict and
5’-tailed mirtrons appear to be more prone to uridylation due to the 3’ terminal “AG” of
consensus splice sites which is Tailor’s, a terminal uridylyl transferase, preferred
substrate. This bias suggests that uridylation of mirtrons is used to specifically suppress
their biogenesis. Thus, not only is there selective pressure working to limit mirtron
function, but also a targeted modification is applied that further reduces functionality.
Here, we investigate these seemingly contradictory miRNA species through
probing biogenesis mechanism of tailed mirtrons in humans. Despite their seeming
disfavored biogenesis, mirtrons remain abundant (Ladewig et al., 2012; Jiayu Wen et al.,
2015). We show that 3’-tailed mirtrons in mammals likely follows what was found in
Drosophila. 5’-tailed mirtrons, on the other hand, are produced by the activity of an
endoribonuclease, which we identified to be RNaseP. This is the enzyme that is
responsible for removal of 5’ leader segments from tRNA precursors, a structure that
mirrors the base of 5’-tailed mirtron hairpins (Nayef Jarrous & Reiner, 2007). We also
find that dysregulation and accumulation of tRFs seen in cancer correlates with a similar
accumulation of 5’ tailed mirtrons. This further intertwines processing of 5’-tailed
mirtrons with tRNA processing and suggests that the importance of mirtrons might not lie
in normal cell physiology, but rather is more impactful during disease processes.
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3.3 Results
3.3.1 5’-Tailed Mirtrons Are Characterized by G-quartet Containing Precursors
To investigate biogenesis of 5’ tailed mirtrons we first sought to identify shared
motifs in these miRNAs. To do this, we applied the seqlogo algorithm to the first 20
bases of small RNAs produced from human 5’-tailed mirtron hairpins (Fig 3.1A-B)
(Crooks, Hon, Chandonia, & Brenner, 2004). Comparing all species, similar motifs are
apparent. 5’ arms are comprised primarily of “G” residues while 3’ arms are typically C
and U residues, likely representing intronic polypyrimidine (ppy) tracts. This situation
was likewise noted in prior efforts to assess sequence elements in mammalian mirtrons
(Jiayu Wen et al., 2015). This suggests that G rich stretches arising adjacent to ppy
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elements might be sufficient to lead to 5’-tail mirtron formation. Also, the higher
confidence G quartet at the beginning of the 5’ arm suggests a major role for hairpin
structure in biogenesis of 5’-tailed mirtrons. To confirm this, we assessed the prevalence
of G quartets in all human introns relative to 5’ tail mirtron encoding introns, showing
significantly higher G quartet occurrence in mirtrons (Fig 3.2). Thus, biogenesis of 5’tailed mirtrons appears linked to RNA structure, specifically polyG tracts. To further
connect 5’-tailed mirtron biogenesis to nucleotide content we compared the free energy
(G) and GC content of 767 canonical miRNAs
and 404 5’-tailed mirtrons (Fig 3.3). As a class,
5’-tailed mirtrons show much high GC content
relative to most miRNAs. Interestingly, this does
not seem to correlate with a substantially
different energy profile. If mirtron hairpin
energy is greatly divergent from conserved
miRNAs this might lead to incompatibilities in
Ago loading. Considering the bias of 5’ tailed
mirtrons for G quartets and high GC content this
suggested that part of their biogenesis might be
linked to being challenging substrates for

Figure 3.2: G-Quartets in All Introns and 5’Tailed Mirtrons. 5’-tailed mirtrons have
significantly more G quartets compared to
all introns. (*p≤0.05).

RNases. To examine this possibility, we
investigated the impact of major 5’-3’ turnover RNases, Xrn1 and Xrn2, in 5’-tailed
mirtron production (Valen et al., 2011).
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Using public data from XRN 1/2 depleted cells, 5’-tailed mirtrons are expressed
at a significantly higher level compared to control (Fig 3.4 A-B). A higher level of
mirtron expression was observed as well as species that were completely absent in
control conditions appeared after XRN1 1/2 knockdown. Initial reporting of these
datasets revealed a similar situation, however, this study benefits from a formalized
annotation of 5’-tailed mirtrons (Jiayu Wen et al., 2015).
These data suggest that exoribonuclease activity antagonizes mirtron production,
which led us to investigate the characteristics of mirtrons that only accumulate in Xrn1/2
knockdown datasets. A notable feature of XRN-eliminated mirtrons is the presence of
heterogeneous isoforms, where over half were represented by two or more isoforms (Fig
3.5).

Figure 3.3: Hairpin Energy vs GC Content. Comparison of ∆G (X axis) and GC (Y axis)
contents in 767 canonical miRNAs and 404 5’-tailed mirtrons. Density overlays show
separation of the two groups based on GC content, but not ∆G.
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This Imprecise processing is consistent with a biogenesis mechanism that is not
dedicated to mirtron production, unlike the reliability of Drosha to generate precise
hairpin ends. Focusing on a well-expressed mirtron, hsa-miR-3620, greater heterogeneity
is seen for 5p arm small RNAs (Fig 3.6). Moreover, the greatest isoform diversity is seen
at the 5’ end of the 5p read, which is problematic as this shifts the identity of a miRNA’s
targets. It also hints that 5’-tail removal is not occurring in a deliberate fashion, suggests
a role for XRN activity in limiting 5’-tailed mirtron accumulation, and that this class of
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3.3.2 Processing of the ‘-tailed Mirtron, has-miR-5010
To dissect the biogenesis of 5’ tailed mirtrons we examined hsa-miR-5010 which
is located in ATP6V0A1 (Fig 3.7). hsa-miR-5010 is one of the most highly expressed 5’tailed mirtrons and exhibits relatively consistent 5p arm processing. As a point of
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comparison, we also examined the mouse 3’-tailed mirtron mmu-miR-668, which is
likewise a high confident tailed mirtron (Fig 3.7) (Ladewig et al., 2012; Seitz et al.,
2004). While there is a homolog of mmu-miR-668 in humans that likewise resides in a

Figure 3.7: UCSC Tracks of has-miR-5010and mmu-miR-668.
Supplementary Figure
1. UCSC Screenshot of hsa-miR-5010 and mmu-miR-668 Used in This
Study.

large miRNA cluster it is only a 3’-tailed mirtron in mice (Seitz et al., 2004). Based on
the tendency for 5p-tailed mirtrons to harbor polyG tracts we investigated the effect of
adding polyG tracts into the tails of hsa-miR-5010 and mmu-miR-668. After each mirtron
was cloned into an expression vector, either a 12G element or a mixed identity 20nucleotide insert was placed in the tail of each mirtron (Fig 3.8 A-C). Wildtype, polyG,
and insert constructs were transfected into HEK 293 cells and expression of the mirtron
assessed by small RNA sequencing. Consistent with our observations regarding 5’-tailed
mirtrons, addition of the polyG tract led to greater accumulation of hsa-miR-5010 reads
while the mixed insert did not (Fig 3.8 A-B). hsa-miR-5010 biogenesis was not perturbed
by insert, and in all cases terminal modifications were not dramatically altered in
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ectopically expressed hsa-miR-5010 reads (Fig 3.8B, Fig 3.9). The opposite was seen for
mmu-miR-668 (Fig3.10 A-B). Both insertions led to decreased expression.
Increased hsa-miR-5010 expression after polyG insertion was verified using a
luciferase assay to assess target silencing (Fig 3.8C, 3.12). For the polyG construct we
observed significant reduction in expression, while very little was seen for WT and insert.
Together these data suggest that mammalian 5’-tailed and 3’-tailed mirtrons are produced

Figure 3.8: Endoribonucleases Process miR-5010. A) Accumulation of expression, determined by small
RNA sequencing, from three mirtron constructs (WT, PolyG and Insert) transfected into HEK 293T.
Visualization of small RNA read alignments from transfection using the “IGV” software. Left shows the
modifications made to the different mirtrons. C) Quantification of luciferase activity from a hsa-miR5010 sensor following cotransfection with WT, Poly G and Insert hsa-miR-5010 expression plasmids.

by very different mechanisms. The presence of additional nucleotides in mmu-miR-668
(3’-tailed) resulted in inactivation, which is like what was observed for miR-1017 in
40

Figure 3.9: Bar Graph Showing Rates of Different Nucleotide Additions.
Quantification of 3’ modifications from transfected hsa-miR-5010 constructs shows
similar profiles to endogenous expressed hsa-miR-5010.

drosophila (Flynt et al., 2010). Inhibition of 3’-5’ exoribonucleases by tail inserts
negatively impacted biogenesis. hsa-miR-5010, in contrast, is enhanced specifically by a
sequence element inhibitory to exoribonucleases. This is consistent with the effects of
Xrn1/2 knockdown on 5’-tailed mirtron expression and suggests that this type of mirtron
is produced by endoribonuclease-mediated severing of tails from hairpins.
Considering the structure of tailed mirtrons, where a double-stranded RNA is connected
to an unpaired region, it is reminiscent of immature tRNAs. Excision of tRNAs from
precursors is carried out by two endoribonucleases: the 5’ Leader cut by RNaseP and the
3’ Trailer by RNaseZ (Hopper & Nostramo, 2019). In the case of 5’-tailed mirtrons the
clear fit would be RNaseP. This enzymatic activity is carried out by a multi-subunit
complex that coordinates the activity of a ribozyme. To assess the role of RNaseP in
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mirtron expression, siRNAs targeting the Rpp30 subunit of RNaseP were transfected into
HEK cells followed by a second transfection with WT hsa-miR-5010 constructs (Fig 3.10

Figure 3.10: Exoribonucleases Process miR-6668. A) Three mirtron constructs (WT, Poly G and Insert)
were transfected into HEK 293T cells. In the Poly G, 12 “G”s and in the “Insert” 20 random
nucleotides were inserted on the 3p tail of mmu-miR-668. Reads from RNA sequencing analysis were
visualized using “IGV” software. Mirtrons with Poly G tract showed higher mature mirtrons.
Untemplated “T” nucleotide reads at the 3’ end are observed mostly on 3p end of the 3p arms but less
than that in 5’-tailed mirtrons. B) Hairpin mapping reads were normalized based on the total number of
reads in each library. WT showed much higher matured mirtrons.

A-B). After this, small RNA sequencing libraries were created to assess differences in
expression and processing. The data shows that the expression of hsa-miR-5010 in Rpp30
knockdown is decreased by half compared to control libraries implicating RNaseP as a
factor necessary for 5’-tailed mirtron expression (Fig 3.11 A). This led us to evaluate
differences in RNAs produced from hsa-miR-5010 in control and Rpp30 knockdown
42

A

B

Figure 3.11: miR-5010 Sequencing. A) Quantification of hsa-miR-5010 by high throughput sequencing
after transfection of control or Rpp30 siRNAs followed by WT hsa-miR-5010 expression construct. B)
Effects of Rpp30 knockdown on 5’ arm heterogeneity. Dominant position found are listed as 1,2,3 as
show on the hairpin.

libraries. We detected three different types of endings at the 5’ end of a mature hsa-miR5010 (Fig 3.11B). Most of the reads (94%) in control started with “AG” (position 2) and
when a “U” is added to the 3’ end by uridylation, a 2 nt overhang is obtained which
resembles a perfect Drosha product. This is while only 4% of the reads start with “CAG”.
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Figure 3.12: Knockdown efficiency of Rpp30 dsiRNAs.
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Figure 3.13: No change in hairpin 3’ residue identity seen after Rpp30
knockdown. Single nucleotide addition, which when combined with cleavage at
the “2” 5’ position yields an ideal Drosha product mimic.

On the other hand, in Rpp30 knockdown libraries, 5’ processing has been perturbed and a
shift in the first base is observed and the rate of the “AG” is reduced to 75%. This
suggests that Rpp30 knockdown has affected the 5’ end processing of hsa-miR-5010. A
similar analysis was applied to isoforms differing at the 3’ end but there was no
significant difference detected, further implicating Rpp30 in shaping the 5p arm of 5’tailed mirtrons (Fig 3.13).
To verify the role of RNaseP in processing hsa-miR-5010, we sought to
reconstitute 5’-tail removal using immunopurified complexes (Fig 3.14 A-B). Antibodies
against Rpp20, another RNaseP subunit, were used to isolate complexes. In vitro
synthesized hsa-miR-5010 primary intron transcripts were incubated with these isolated
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complexes or with beads bound to mock anti-rabbit IgG antibodies. Incubation with
isolates led to significant accumulation of the ~85 nt hairpin of hsa-miR-5010 in the
RNaseP IP, but not the IgG control. In whole lysate incubation, the RNA is degraded by

A
B

Figure 3.14: RNaseP Immunoprecipitation. A) Incubation of radiolabeled hsa-miR-5010 primary
intron with immunoprecipitated RNaseP (Rpp20 Ab), mock pull down (cont Ab), or whole cell
lysate. Processing products were separated on a PAGE-urea gel. B) RT-PCR of RNaseP complex
RNA subunit to verify complex isolation.

cellular RNases. Immunoprecipitation efficiency was verified by RT-PCR of the RNA
subunit of RNaseP, which was greatly enriched in the Rpp20 IP condition relative to
control IgG (Fig 3.11B). These results indicate that not only is RNaseP necessary for
processing of hsa-miR-5010, but that it is also sufficient to recapitulate removal of the
tail of this 5’-tailed mirtron.
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3.3.3 5’-Mirtron expression is linked to RNaseP activity
To assess the effects of Rpp30 loss and its correlation with 5’-tailed mirtrons, we
compared the expression of all 5’-tailed mirtrons after Rpp30 knockdown to levels found
in control libraries (Fig 3.15). We find that after knockdown of Rpp30 statistically
significant changes in 5’-tailed mirtron expression are almost entirely seen in down
regulated species. This is apart from G values which were not predictive of significant
down regulation of 5’-tailed mirtrons in Rpp30 knockdown libraries. This reinforces our

Figure 3.15: RNaseP processing and global 5’-Tailed Mirtron expression. Scatter plot
showing expression of 5’-tailed mirtrons following Rpp30 knockdown. Blue colored
data points represent statistically significant changes. Red represents non-significant
changes. Data point shape denotes stable (∆G < -26) or less stable (∆G > -26).
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observation that strength of RNA fold does not typically track with expression. The
exception is the handful of outliers, which do exhibit lower ∆G values. However, outliers
do not seem to respond consistently to Rpp30 knockdown, suggesting that these changes
might be more related to host gene expression changes than instructive of changes in
biogenesis.
Given the apparent connection of 5’-tailed mirtrons to RNaseP activity we sought
to correlate changes in mirtron expression with biogenesis of tRFs (Fig 3.16 A-B). In
small RNA populations, a significant group appear to be derived from pieces of tRNAs
(Maute et al., 2013). tRFs are not simply degradation products, but are actively loaded
into Ago proteins (Kuscu et al., 2018; Lyons, Fay, & Ivanov, 2018; Shigematsu & Kirino,
2015) Production of tRFs occurs through heterogeneous pathway with most segments of
tRNA clover leaf structures giving rise to small regulatory small RNAs (Yu et al., 2020).
While the function of tRFs is controversial, their expression has been correlated with an
oncogenic phenotype (Yu et al., 2020). This suggests that cancer cells have a
dysregulated tRNA biogenesis, which might also impact 5’-tailed mirtrons. Indeed, after
surveying public small RNA sequencing from several cancer types we generally observe
greater expression of 5’-tailed mirtrons relative to control tissues (Fig 3.16A). In all cases
the mirtrons were either more abundant in cancer or equally distributed between cancer
and norm. Decrease in cancer was not observed. Intriguingly, the degree to which 5’tailed mirtrons are elevated, tracks almost exactly with the abundances of tRFs. The
exception in this situation is lung cancer where mirtrons were enriched to the same
degree as tRFs. Even with this outlier, correlation between 5’-tailed mirtrons and tRFs
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was clear (Fig 3.16B). These results suggest a compelling correlation between changes in
tRNA processing and 5’-tailed mirtrons, reinforcing a shared biogenesis mechanism.

A

B

Figure 3.16: tRFs and 5’-Tailed Mirtrons Expressions. A) Expression of 5’-tailed mirtrons and tRFs
in cancers listed on x-axis. Values are relative difference of RPM values (cancer-norm)/(cancer +
norm). Letters above plots are significance groups determined by TukeyHSD. B) Plot of Mean
relative difference of cancer vs norm in 5’-tailed mirtrons and tRFs plotted by tissues in “B”. R2
value indicated.

3.4 Discussion
In this study, we identified how a large class of human non-canonical miRNAs,
5’-tailed mirtrons, are processed (Fig 4) (Holzmann et al., 2008; Zia & Flynt, 2018). This
class of miRNA exhibits distinct features such as high G content on 5’ arms that appears
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to be a complement to 3’ splice site adjacent ppy tracts. Prior reports on mirtron features
report high GC content (J. Wen et al., 2015; J. O. Westholm et al., 2012). Their
accumulation appears to be highly antagonized by the activity of 5’-3’ exoribonucleases
such that when this enzymatic activity is genetically depleted expression of 5’-tailed
mirtrons increases ~4 fold. Moreover, following XRN 1/2 knockdown 5 times as many
mirtron species become detectable. Linked to inhibition of 5’-3’ processing we also
observe extreme 5’ arm read heterogeneity. Together these data suggest an antagonistic
role for 5’ turnover pathways in 5’-tailed mirtron biogenesis. Consistent with this,
insertion of a 12G tract into a high-confidence human 5’-tailed mirtron, hsa-miR-5010,
led to a nearly 4-fold increase in mature RNA expression. This is the opposite result to
what was observed when testing sequence requirements for miR-1017, a 3’-tailed mirtron
encoded in the Drosophila genome. For miR-1017, exoribonuclease activity of the RNA
exosome was essential for 3’ tail removal. Interestingly, when we perform a similar test
with a mammalian 3’-tailed mirtron, mmu-miR-668, a similar result was found. Thus, it
would seem both vertebrate and invertebrate 3’-tailed mirtrons likely share a biogenesis
mechanism–exoribonuclease processing. They also suggest for mammalian 5’-tailed
mirtrons tail removal is likely carried out by an endoribonuclease. Together these results
indicate a fundamentally different biogenesis mechanism underlies 5’-tail and 3’-tail
mirtrons.
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In our studies we implicate the activity of RNaseP in the processing of 5’tailed
mirtrons. This ribozyme containing complex has a role in the maturation of tRNAs by
removing 5’ leader sequences from precursors. However, studies have found RNaseP to
interact and cleave a variety of additional transcripts such as pre-rRNA, snoRNAs, along
with additional nuclear RNAs such as the HRA1 antisense RNA (Chamberlain, Pagan,
Kindelberger, & Engelke, 1996; Coughlin, Pleiss, Walker, Whitworth, & Engelke, 2008;
Marvin et al., 2011). Thus, it is not unreasonable to expect this complex to moonlight
with mitron primary intron transcripts. Moreover, binding affinity of RNaseP is biases to

Figure 4: 5’-tailed mirtrons can undergo two different processes. They either are processed by
RNaseP and produce miRNAs or undergo turnover by XRN exoribonuclease activity and will not
be targeted by RNaseP.
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nucleotide homopolymers, with greatest preference for polyG, a defining characteristic of
5’-tailed mirtrons. This with the tRNA-like single-stranded to double-stranded structure
of 5’-tailed mirtrons further reinforces confidence of RNaseP as the likely 5’-tail
“severing” enzyme.
One unclear aspect of 5’-tailed biology is their hyper abundance in mammalian
genomes. RNaseP is a universal enzyme that is found in all cells and would be able to
participate in 5’-tailed mirtron biogenesis. Likewise, as 5’-tailed mirtrons appear to arise
from accumulation of polyG tracts adjacent to the universal eukaryotic ppy tract splicing
element they should arise at the same rate across many kingdoms (Jacob et al., 2018).
What then leads to the radical accumulation in mammalian genomes? The answer is
likely related to the extreme intron length seen in mammals, and the more elaborate
alternative splicing patterns (Bell, Cowper, Lefranc, Bell, & Screaton, 1998; Hube &
Francastel, 2015; Roy, Kim, Xing, & Lee, 2008). We propose two possible scenarios.
First, as do the massive length of mammalian introns, exact placement of strong splicing
elements such as the ppy are highly favored. A polyG tract could then form through
neutral evolutionary process to the point that a viable pre-mirtron hairpin arises, which
then become subject to negative selection. Unfortunately, there is significant constraint
on the ppy tract such that 5’-tail mirtron 3p arms are unable to acquire hairpin disrupting
mutations. Harboring the 5’-tailed mirtron is preferable to degrading the strength of the
ppy track. In the second scenario, the 5’ arm polyG sequence has a role in modulating
splicing as a cis-element. Here by forming a hairpin that occludes the ppy tract, it might
lead to alternative 3’ splice choice, and thereby contributing to the greater splicing
complexity favored by mammalian gene expression programs. The G-quartets could also
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be cis-elements that influence alternative splicing through recruitment of hnRNPF (H.
Huang, Zhang, Harvey, Hu, & Cheng, 2017). In this second scenario 5’-tailed mirtron
expression is an unintended outcome of a different, favorable arrangement.
Considering this case, perhaps 5’-tailed mirtrons can be written off as little more
than genomic detritus. They may shape genomes through disfavoring polyG tracts in
splice adjacent ppy elements, and thereby apply constraints on ppy neighborhoods.
However, it might not be a role in normal cell physiology that should draw the attention
of 5’-tailed mirtron function. As potential regulatory molecules that are diverted from
Ago loaded by multiple mechanisms such as XRN activity and inhibitory nucleotide
addition, these mechanisms could become corrupted to serve the subversive genetics of
cancer cells. Indeed, we find a trend towards increased 5’-tailed mirtron expression in
cancer-derived small RNA datasets. A similar, and possibly mechanistically related,
situation is seen with tRFs, which are also amplified in cancer cells. Further, components
of RNaseP are upregulated in nearly all cancer types (Uhlén et al., 2015; Uhlen et al.,
2017). Both types of non-canonical miRNAs are RNaseP substrates with unclear roles in
regulation of gene expression. They are excellent candidates for exploitation by cancer
biology to induce survival promoting gene expression changes as well as excreted RNAs
could be used to modulate the function of stromal cells within the tumor
microenvironment.
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3.5 Materials and Methods
3.5.1 Cell Culture, cloning and transfection.
Human embryonic kidney (HEK-293T, ATCC) cells were grown in Dulbecco’s
modified Eagle’s medium (DEMEM, GIBCO) supplemented with 10% Fetal Bovine
Serum (FBS) and 1% Penicilline-Streptomycine (GIBCO). Cell cultures were maintained
at 370 C in 5% CO2, 95 % air humidified atmosphere. The constructs to over express the
mirtrons: mmu-miR-668 and hsa-miR-5010; were cloned in the pcDNA 3.1 vector. All
the clones were transfected into the HEK-293T cells at 90% confluency using FuGene 6
as transfection reagent according to the manufacturer’s instructions (Promega). dsiRNAs
targeting Rpp30 (10 nM) were transfected into HEK 293 cells using Lipofectamine 3000
reagent according to the manufacturer’s instructions (Invitrogen). Target are available
on www.idtdna.com. Two days after transfection, the total RNA was extracted and used
for qRT-PCR or RNA sequencing (Sup Table 1).

3.5.2 Luciferase Assay
To evaluate functionality of mirtrons constructs a dual reporter luciferase assay
was used. Briefly, the hsa-miR-5010 hairpin was cloned downstream of Renilla into the
psiCHECK2 vector (Table 1) Then the plasmid constructs (150 ng) were transfected into
HEK 293T cells at their 90% confluency using Dual-Luciferase Reporter Assay System
(Promega). The Luciferase activity was measured 72 h (48h for DsiRNA and 24 h for
plasmid constructs) according to manufacturer’s instructions. Four replicates were used
to measure the Luciferase activity and calculated as the ratio of Renilla:Firefly.
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3.5.3 RNA Isolation, qRT-PCR, Sequencing and Analysis pipeline.
Total RNA was collected from the transfected HEK cells by Trizol extraction
protocol (Invitrogen,Carlsbad, CA) and 2 μg of each sample was used to make small
RNA libraries for sequencing. cDNAs was prepared using RevertAid First Strand cDNA
Synthesis Kit (Thermoscientific) according to the manufacturer’s recommendation to
perform qRT-PCR (BioRad) (Sup Table 1). Sequencing was performed on the Illumina
NextSeq platform, and adaptor were clipped using fastx_clipper (Hannon, 2010). Bowtie
was used for alignments to hg19 or mm10 (Langmead, Trapnell, Pop, & Salzberg, 2009).
Next, samtools and bedtools were used to quantify reads and examine alignments (H. Li
et al., 2009; Quinlan & Hall, 2010). The EdgeR R package was used to assess 5’-tailed
mirtron expression in libraries (Robinson, McCarthy, & Smyth, 2010).

3.5.4 In Vitro Transcription
Synthetic full length hsa-miR-5010 intron RNA was generated by in vitro
transcription with MEGAscript® T7 Kit (Invitrogen) using full length intron PCR
amplification with a T7 encoding forward primer (Sup Table 1). RNAs were radiolabeled
by addition of alpha-P32 UTP to the reaction.

3.5.5 Immunoprecipitation and In Vitro Enzymatic Processing.
For immunoprecipitation, the HEK 293T cells were lysed in 0.1% NP-40, 800 nM
NaCl, 20 mM Tris at 8.0, 30 mM HEPES, 2 mM Magnesium Acetate, Protease Inhibitor
by sonicated. The insoluble fraction was removed by centrifugation at 14,400 rpm for 15
minutes at 40 C. After that the supernatant was incubated for 2 hour with 10 uL of Rpp20
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Antibody (Novus Biologicals) immobilized Dynabeads™ Protein G Immunoprecipitation
Kit (Invitrogen). The beads were washed five times with IP buffer (0.1% NP-40, 20 mM
Tris at 8.0, 30 mM HEPES, 2 mM Magnesium Acetate, 150 mM Potassium Acetate),
using a magnetic stand. The enzyme assay reaction was performed at 370 C for 15
minutes with incubation buffer (5% PEG, 10 mM MgCl2, 50 mM Tris-HCl, 100 nM
NH4Cl) by incubating RNAs with RNaseP-bound or control IgG-beads. Beads were
pelleted and the supernatant was loaded on 8% urea-acrylamide gel and the gel was
exposed to phosphor imaging plate (Fujifilm) and was read by Typhoon FLA 7,000. In a
separate run, beads were subject to organic extraction followed by RT-PCR of RNaseP
RNA subunit.

3.5.6 Cancer Small RNA-Metanalysis.
Public data from NCBI was used to analyze 5’-tailed mirtron and tRF expression
(Table 2). Cancer-norm pairs were from same studies. Alignment and read counting was
performed as described above. tRFs coordinates were obtained for hg19
http://gtrnadb.ucsc.edu. Counts were normalized to million of reads mapping (RPM) in
the corresponding library. After, relative difference was calculated as (cancernorm)/(cancer+norm).
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Table 1: Primers and DsiRNAs Used.
Construct

Sequence

RPP30 F

tcagcatggcggtgtttgcag

RPP30 R

gcggctgtctccacaagtccg

B-Actin F

catgtacgttgctatccaggc

B-Actin R

ctccttaatgtcacgcacgat

hsa-miR-5010 T7 F

taatacgactcactataggTGAGTACCTCTCTCCGGGC

hsa-miR-5010 R

ctggggaatgggagacacaaaatcc

mmu-miR-668 F

gtaagtgtgcctcgggtgag

mmu-miR-688 R

cattcacacggagcccactc

hsa-miR-5010 + Strand, Luciferase

ggccgcCCATCC CCCactgacCCATCCCCCactgacCCATCCCCC

insert

actgacCCATCCCCCc

hsa-miR-5010 - Strand, Luciferase

tcgagGGGGGATGGgtcagtGGGGGATGGgtcagtGGGGGATGGgtcagtGGG

insert

GAT

dsiRNA used

hs.Ri.Rpp30.13.1

dsiRNA used

CD.Ri.195363.13.5

Rpph1F

ccactgatgagcttccctcc

Rpph1F

ggaggagagtagtctgaattgg

Table 2: Public Data Used From NCBI.
Cancer

Cancer

Norm

Lung

SRR14634327,SRR14634347,SRR14634359

Melanoma

SRR14510928,SRR14510929,SRR14510930

SRR14634273,SRR14634279,S
RR14634283
SRR14510925,SRR14510926,S
RR14510927
SRR333656,SRR333658,SRR33
3660
SRR8932123,SRR8932125

Bladder
Colorectal
cervical
Breast

SRR333655,SRR333657,SRR333659
SRR8932122,SRR8932124
SRR11095745,SRR11095746,SRR11095747
, SRR11095748
SRR8330380,SRR8330384,SRR8330374,
SRR8330376,SRR8330378,SRR8330382
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SRR11095741,SRR11095742,S
RR1109574, SRR11095744
SRR8330375,SRR8330377,SRR
8330379,
SRR8330381,SRR8330383,SRR
8330385

CHAPTER IV – CONCLUSION AND FUTURE DIRECTION
Since the discovery of the mirtrons this is the first study working on the
biogenesis of 5’-tailed mirtrons and 5’ tail removal. We answered the most important
question about their biogenesis demonstrating that 5’-tailed mirtrons are processed
through “Endoribonuclease” activity. We then identified the “RNaseP” complex as the
main enzyme complex involved in this process which is a remarkably influential
discovery in the field of mirtrons biogenesis specifically in that 86% of the mirtrons are
5’-tailed mirtrons. Additionally, we uncovered that XRN 1/2 family enzymes contribute
in the 5’-tailed mirtrons turn over. We also showed the relationship between the changes
in the mirtrons biogenesis and different human cancers which emphasizes on the
importance of their biogenesis and modifications on their structures especially
“Uridylation” on the 3p end. By altering the involved biogenesis factors, not only the 5’tailed mirtron biogenesis is perturbed, but also their arm bios is subjected to shift from
one arm to another. This has been reported in cancer studies as well (L. Chen et al.,
2018; Z. Zhang et al., 2019). Therefore, studying the relationship between uridylation on
3p end of mirtrons and their biogenesis with different cancers to elucidate the molecular
mechanism in this process can be an outstanding future topic.
Moreover, it is unclear exactly how many of other subclasses of ncRNAs are
expressed in all aspects of living organisms and especially higher mammalians.
Therefore, we postulate that there might be more examples of alternative non-canonical
pathways resulting in small RNAs. Hence, revealing more details of how and to what
extent the genes are regulated through unexplored non-canonical RNAs, appears to be an
enigmatic prospect of this field. This could be applied to other Drosha independent
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pathways such as shRNAs in which they generate miRNAs. This can be a leading
indication to investigate whether RNaseP complex is processing shRNAs in the same
fashion as mirtrons are.
To date, about 500 mirtrons have been annotated in the human genome, covering
almost 20% of the total canonical miRNA population. Besides, remarkable elaborations
have been disclosed in understanding their biogenesis details. However, still some
uncertainties regarding mirtron’s turnover, export pathways and modifications requires
future explorations. Additionally, experiments are needed to identify targets of these noncanonical miRNAs to address their biological function and significance. This can be a
boon for researchers in the field to uncover the relevance of mirtrons to diseases. This has
become more challenging in mirtrons biogenesis and functionality after we revealed that
there is a strong correlation with changes in 5’-tailed mirtron processing with tRNA,
proposing shared biogenesis mechanism. In addition, by revealing more structural
features of mirtrons such as high G content, the path to define more reliable
computational algorithms of discovering novel mirtrons seems more feasible. By this,
few mirtrons that might have been incorrectly annotated as mirtrons can be removed from
the list. Moreover, defining algorithms that help recognizing the cleavage site of the
RNaseP complex on mirtrons seems an area in which much effort could be invested.
There has been attempts to introduce artificial mirtrons as therapeutic implements;
however, more evidence and considerations seem indispensable. This becomes more
crucial now that pharmaceutical companies and research laboratories are racing to
pioneer RNAi-based drugs to treat diseases like cancers and Alzheimer’s. This has
become more challenging during the COVID-19 pandemic and global accessibility and
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application of RNA-based vaccines which signifies increasing demands on the emergence
of new technologies and discoveries in RNA-based drugs as a prominent approach to
overcome ever-challenging and even future diseases. Our findings here in this study,
regarding mirtron G content and polyG tract blocking the maturation process from 5’ end
might be applicable in designing better siRNAs. About half of the mirtrons with lower
∆G were downregulated in RNaseP knockdown. Therefore, better siRNAs can be
designed by considering ∆G level of the designs. On the other hand, more considerations
on the 5’ end of the siRNAs seems reasonable to avoid being degraded by ribonucleases
such as XRN 1/2 before they are delivered in the cell to target the gene of interest.
On the other hand, another area which seems essential to provide more evidence
is to assess as to why mirtrons have emerged since they are reported to be poorly
conserved and most of them are not retained during the evolution. Perhaps the answer
could be found in the natural selection as their primary sequence has evolved quickly.
This infers that while much has been done on mirtrons in recent years, there is still many
studies to be accomplished in their evolutionary investigations.
Overall, our findings on RNaseP and XRN family provides influential small RNA
functional applications in future studies revealing biogenesis pathways of other known
and unknown ncRNAs.
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